RYAH Group (CSE: RYAH) is a leading data technology company in plant-based medicine committed to providing valuable insight and transforming patient care through big data and artificial intelligence. According to a recent article, which contains excerpts from a RYAH blog post, “The company is working to unearth breakthrough discoveries that will reshape the understanding of … Continue reading “BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Unearthing Breakthrough Discoveries That Will Reshape Understanding of Plant-Based Medicines”
RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received ISO 13485:2016/MDSAP and EN ISO 13485:2016 certification for its proprietary Internet of Things (“IoT”)-powered dry herb inhaler (the “RYAH Smart Inhaler”) and software application associated with the device. According to the update, the certification is a regulatory requirement and an international … Continue reading “BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Certification for IoT-Powered Dry Herb Inhaler, Software”
Multiple ongoing studies are researching the relationship between medical cannabis and cancer treatment The viability of clinical studies within the sector is hampered by lack of exact measurement of a patient’s intake RYAH Group intends to resolve this issue with the launch of it’s proprietary RYAH Smart Dry Herb Inhaler The company successfully delivered on … Continue reading “RYAH Group Inc. (CSE: RYAH) to Deliver Solutions for Clinicians Examining Cannabis Efficacy in Cancer Treatment”
Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal … Continue reading “RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market”
German Social Democrat-led coalition expected to liberalize medical cannabis market Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH … Continue reading “German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study”
RYAH Group (CSE: RYAH) today announced its entry into a non-binding letter of intent (“LOI”) with Omni Services LLC (d/b/a “Omni Medical Services” or “Omni”), a leading physician-owned and operated telehealth, cannabis clinic and certifications company operating in the United States, with respect to the potential acquisition of 100% of the business and assets of … Continue reading “BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Enters LOI to Acquire Omni Services LLC”
RYAH Group (CSE: RYAH), a connected device and big data and technology company, in a recent blog post provided insight into the cannabis medical space in Brazil, the largest South American country both in size and population, boasting a GDP per capita of $15,388. A recent article that contains excerpts from the post notes that … Continue reading “BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Well Qualified to Provide Global Insight into Medical Cannabis”
Palliative care focuses on providing end-of-life care for chronically ill patients Preliminary research suggests cannabis relieves pain, appetite loss, anxiety RYAH is the leader in volume-control technology for plant-based medicine RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data With a mission to advance remote-health solutions and analytics-based patient … Continue reading “RYAH Group Inc. (CSE: RYAH) Positioned to Impact Palliative Care with AI-Powered Plant-Based Solutions”
RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate … Continue reading “BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices”
RYAH Group is a digital healthcare analytics and technology company focused on developing tools that provide patients and doctors with the ability to accurately manage the intake in plant-based treatment The company recently revealed its participation at the Wall Street Reporter’s ‘Next Super Stock’ livestream conference held on September 23, 2021 RYAH Group (CSE: RYAH) … Continue reading “RYAH Group Inc. (CSE: RYAH) Reveals Attendance at the Wall Street Reporter’s Next Super Stock Livestream Conference”
